Regulated cell death and its role in Alzheimer’s disease and amyotrophic lateral sclerosis

2024/04/07 by Dietmar Rudolf Thal, Klara Gawor, Sebastiaan Moonen · 25 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Inflammasome and immune disorders #Autophagy in Disease and Therapy #Alzheimer's disease research and treatments

paper · doi:10.1007/s00401-024-02722-0

Citations

• Neuropathological stageing of Alzheimer-related changes
• Necrosome complex detected in granulovacuolar degeneration is associated with neuronal loss in Alzheimer’s disease
• Widespread CNS pathology in amyotrophic lateral sclerosis homozygous for the D90A SOD1 mutation
• Pyroptosis in Alzheimer’s disease: cell type-specific activation in microglia, astrocytes and neurons

Cited by

• The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease
• Amyloid-beta induces distinct forms of cell death in different neuronal populations
• Alzheimer's disease: insights into pathology, molecular mechanisms, and therapy. [europepmc]
• The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disease. [europepmc]
• Xenografted human iPSC-derived neurons with the familial Alzheimer's disease APP V717I mutation reveal dysregulated transcriptome signatures linked to synaptic function and implicate LINGO2 as a disease signaling mediator. [europepmc]
• Neuronal regulated cell death in aging-related neurodegenerative diseases: key pathways and therapeutic potentials. [europepmc]
• Autophagy-lysosomal-associated neuronal death in neurodegenerative disease. [europepmc]
• Functional Relationships between L1CAM, LC3, ATG12, and Aβ. [europepmc]
• Identification of early Alzheimer's disease subclass and signature genes based on PANoptosis genes. [europepmc]
• Physical Exercise Decreases Complement-Mediated Synaptic Loss and Protects Against Cognitive Impairment by Inhibiting Microglial Tmem9-ATP6V0D1 in Alzheimer's Disease. [europepmc]
• Identification and validation of diagnostic biomarkers for temporal lobe epilepsy related to ferroptosis and potential therapeutic targets. [europepmc]
• Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer's disease. [europepmc]
• Role of tau versus TDP-43 pathology on medial temporal lobe atrophy in aging and Alzheimer's disease. [europepmc]
• Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers. [europepmc]
• Astrocytes Contribute to Motor Neuron Degeneration in ALS via the TRAIL-DR5 Signaling Pathway. [europepmc]
• PEMFs Restore Mitochondrial and CREB/BDNF Signaling in Oxidatively Stressed PC12 Cells Targeting Neurodegeneration. [europepmc]
• Psychoactive substances: novel molecular insights and therapeutic potential for Alzheimer's disease. [europepmc]
• Organelle stresses and energetic metabolisms promote endothelial-to-mesenchymal transition and fibrosis via upregulating FOSB and MEOX1 in Alzheimer's disease. [europepmc]
• Role of lipocalin-2 in amyotrophic lateral sclerosis. [europepmc]
• Identification and validation of PANoptosis-related biomarkers in Alzheimer's disease via single-cell RNA sequencing and machine learning. [europepmc]
• Mechanistic advances in exercise‑mediated regulation of autophagy dysfunction in Alzheimer's disease (Review). [europepmc]
• Programmed cell death: a promising management for Alzheimer's disease. [europepmc]
• Focus on necroptosis: its role in the pathogenesis and therapeutic potential of osteoarthritis. [europepmc]
• The Central Role of Neuronal Cell Death in Alzheimer's Disease Pathobiology. [europepmc]
• USP39 inhibits MLKL phosphorylation and deubiquitination to suppress necroptosis of nucleus pulposus cells and attenuate intervertebral disc degeneration [europepmc]